Intestinal absorption of the acetamiprid neonicotinoid by Caco-2 cells: Transepithelial transport, cellular uptake and efflux

Journal of Environmental Science and Health - Part B Pesticides, Food Contaminants, and Agricultural Wastes

Volumn 43, Issue 3, 2008, Pages 261-270

  Brunet, Jean Luc ^a   Maresca, Marc ^b   Fantini, Jacques ^b   Belzunces, Luc P ^a  

^a Laboratoire de Toxicologie Environnementale   (France)

^b University of Mediterranée   (France)

Author keywords

Acetamiprid; Caco 2 cells; Human; Intestinal absorption; Neonicotinoid; Pesticide

Indexed keywords

ACETAMIPRID NEONICOTINOID; INTESTINAL ABSORPTION;

ABSORPTION; CONCENTRATION (PROCESS); PESTICIDES; SODIUM;

CELL CULTURE;

ACETAMIPRID; INSECTICIDE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AALENIAN; ADSORPTION; BIOACCUMULATION; DIGESTIVE SYSTEM; HEALTH RISK; INSECTICIDE; ORGANIC COMPOUND; PUBLIC HEALTH;

ARTICLE; CELL STRAIN CACO 2; DOSE RESPONSE; HUMAN; INTESTINE ABSORPTION; INTESTINE CELL; METABOLISM; PERMEABILITY; PHYSIOLOGY; RISK ASSESSMENT; TEMPERATURE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROCYTES; HUMANS; INSECTICIDES; INTESTINAL ABSORPTION; PERMEABILITY; PYRIDINES; RISK ASSESSMENT; TEMPERATURE;

EID: 41349111510     PISSN: 03601234     EISSN: 15324109     Source Type: Journal    
DOI: 10.1080/03601230701771446     Document Type: Article

References (35)

1. Tomizawa, M.; Yamamoto, I. Structure-activity relationships of nicotinoids and imidacloprid analogs. J. Pestic. Sci. 1993, 18, 91-98.
2. 3H]- imidacloprid in the insect acetylcholine receptor. Pestic. Biochem. Physiol. 1993, 46, 40-46.
3. Tomizawa, M.; Casida, J.E. Minor structural changes in nicotinoid insecticides confer differential subtype selectivity for mammalian nicotinic acetylcholine receptors. Br. J. Pharmacol. 1999, 127, 115-122.
4. Tomizawa, M.; Lee, D.L; Casida, J.E. Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors. J. Agric. Food. Chem. 2000, 48, 6016-6024.
5. Okazawa, A.; Nakagawa, Y.; Akamatsu, M.; Ueno, T.; Nishimura, K. Comparison of the binding activites of chloronicotinyl insecticides toward the nicotinic acetylcholine receptors from rats and houseflies. J. Pestic. Sci. 2000, 25, 40-43.
6. Lansdell, S.J; Millar, N.S. The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity. Neuropharmacology 2000, 39, 671-679.
7. Schulz-Jander, D.A; Leimkuehler W.M; Casida, J.E. Neonicotinoid insecticides: reduction and cleavage of imidacloprid nitroimine substituent by liver microsomal and cytosolic enzymes. Chem.Res. Toxicol. 2002, 15, 1158-1165.
8. Schulz-Jander, D.A; Casida, J E. Imidacloprid insecticide metabolism: human cytochrome P450 isozymes differ in selectivity for imidazolidine oxidation versus nitroimine reduction. Toxicol. Lett. 2002, 132, 65-70.
9. Latli, B.; D'Amour, K.; Casida, J.E. Novel and potent 6-chloro-3-pyridinyl ligands for the alpha4beta2 neuronal nicotinic acetylcholine receptor. J. Med. Chem. 1999, 42, 2227-2234.
10. Chao, L.S.; Casida, J.E. Interaction of Imidacloprid Metabolites and Analogs with the Nicotinic Acetylcholine Receptor of Mouse Brain in Relation to Toxicity. Pestic. Biochem. Physiol. 1997, 58, 77-88.
11. Zywitz, D.; Anastassiades, M.; Scherbaum, E. Simultaneous determination of neonicotinoid insecticides in fruits and vegetables by LC-MSandLC-MS-MS - Methodology and residue data. Deutsche Lebensmittel-Rundschau 2003, 99, 188-196.
12. Suchail, S.; Guez, D.; Belzunces, L.P. Discrepancy between acute and chronic toxicity induced by imidacloprid and its metabolites in Apis mellifera. Environ. Toxicol. Chem. 2001, 20, 2482-2486.
13. Feng, S.; Kong, Z.; Wang, X.; Peng, P.; Zeng, E.Y. Assessing the genotoxicity of imidacloprid and RH-5849 in human peripheral blood lymphocytes in vitro with comet assay and cytogenetic tests. Ecotoxicology and Environmental Safety 2005, 61, 239-246.
14. Yamashita, S.; Furubayashi, T.; Kataoka, M.; Sakane, T.; Sezaki, H.; Tokuda, H. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci. 2000, 10, 195-204.
15. Le Ferrec, E.; Chesne, C.; Artusson, P.; Brayden, D.; Fabre, G.; Gires, P.; Guillou, F.; Rousset, M.; Rubas, W.; Scarino, M.L. In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods. Altern. Lab. Anim. 2001, 29, 649-668.
16. Fantini, J.; Cook, D.G.; Nathanson, N.; Spitalnik, S.L.; Gonzalez-Scarano, F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. USA 1993, 90, 2700-2704.
17. Maresca, M.; Mahfoud, R.; Pfohl-Leszkowicz, A.; Fantini, J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicol Appl Pharmacol 2001, 176, 54-63.
18. Mahfoud, R.; Maresca, M.; Garmy, N.; Fantini, J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol. Appl. Pharmacol. 2002, 181, 209-218.
19. Delezay, O.; Yahi, N.; Tamalet, C.; Baghdiguian, S.; Boudier, J.A.; Fantini, J. Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy. Virology 1997, 238, 231-242.
20. Markwell, M.A.; Haas, S.M.; Bieber, L.L.; Tolbert, N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978, 87, 206-210.
21. Delie, F.; Rubas, W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug. Carrier Syst. 1997, 14, 221-286.
22. Artursson, P.; Palm, K.; Luthman, K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 2001, 46, 27-43.
23. Meaney, C.; O'Driscoll, C. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur. J. Pharm. Sci. 1999, 8, 167-175.
24. Suzuki, H.; Sugiyama, Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 2000, 12, 3-12.
25. Hirohashi, T.; Suzuki, H.; Chu, X.Y.; Tamai, I.; Tsuji, A.; Sugiyama, Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 2000, 292, 265-270.
26. Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S.P.; Deeley, R.G.; Keppler, D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 1994, 269, 27807-27810.
27. Holland, I.B.; Blight, M.A. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 1999, 293, 381-399.
28. Brunet, J.L.; Maresca, M.; Fantini, J.; Belzunces, L.P. Human Intestinal Absorption of Imidacloprid with Caco-2 cells as enterocyte model. Toxicol. Appl. Pharmacol. 2004, 194, 1-9.
29. Fantini, J.; Abadie, B.; Tirard, A.; Remy, L.; Ripert, J.P.; el Battari, A.; Marvaldi, J. Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. J. Cell. Sci. 1986, 83, 235-249.
30. Fukada, A.; Saito, H.; Inui, K. Transport mechanisms of nicotine across the human intestinal epithelial cell line Caco-2. J. Pharmacol. Exp. Ther. 2002, 302, 532-538.
31. Zhang, L.; Brett, C.M.; Giacomini, K.M. Role of organic cation transporters in drug absorption and elimination. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 431-460.
32. Martin, C.; Berridge, G.; Higgins, C.F.; Mistry, P.; Charlton, P.; Callaghan, R. Communication between multiple drug binding sites on P-glycoprotein. Mol. Pharmacol. 2000, 58, 624-632.
33. Tomizawa, M.; Casida, J.E. Selective toxicity of neonicotinoids attributable to specificity of insect and mammalian nicotinic receptors. Annu. Rev. Entomol. 2003, 48, 339-364.
34. Spande, T.F.; Garraffo, H.M.; Edwards, M.W.; Yeh HJC, Pannell, L.; Daly, J.W. Epibatidine - a Novel (Chloropyridyl) Azabicycloheptane with Potent Analgesic Activity from an Ecuadorian Poison Frog. J. Am. Chem. Soc. 1992, 114, 3475-3478.
35. Spande, T.F.; Garraffo, H.M.; Yeh H.J.C.; Pu, Q.L.; Pannell, L.K.; Daly, J.W. A New Class of Alkaloids from a Dendrobatid Poison Frog - a Structure for Alkaloid-251f. Journal of Natural Products 1992, 55, 707-722.